Effects of varenicline and nicotine replacement therapy on arterial elasticity, endothelial glycocalyx and oxidative stress during a 3-month smoking cessation program

Background and aims: The effects of medically-aided smoking cessation on vascular function and oxidative stress are not fully clarified. Methods: One hundred eighty-eight current smokers were randomized to varenicline or nicotine replacement treatment (NRT) for a 3-month period. We assessed: (a) augmentation index (Aix) and pulse wave velocity (PWV); (b) perfusion boundary region (PBR) of sublingual microvasculature (range: 5-25 mu m), an index of the endothelial glycocalyx thickness, using Sideview, Darkfield imaging; (c) the exhaled CO; and (d) the malondialdehyde (MDA) and protein carbonyls (PC) plasma levels, as markers of oxidative stress, at baseline and after 3 and 12 months. Results: After 3 months of treatment, CO, MDA, PC and Aix were decreased in all subjects (median CO: 25 vs. 6 ppm, MDA: 0.81 vs. 0.63 nmol/L, PC: 0.102, vs. 0.093 nmol/mg protein, Aix: 13% vs. 9%, p < 0.05) while PWV remained unchanged. Endothelial glycocalyx integrity showed a greater improvement in the varenicline than the NRT treatment (PBR range 5-9 mu m: 1.07 +/- 0.02 vs. 1.17 +/- 0.02 mu m, p=0.03) in parallel with the greater CO reduction (5 vs. 7 ppm, p= 0.02). At 1-year follow-up, MDA, PC, Aix and PBR at 5e25 mm range were further improved in subjects who abstained from smoking (n=84 out of 188), while the above markers and PWV deteriorated in relapsed smokers (p < 0.05). Conclusions: A smoking cessation program using varenicline or NRT for 3 months resulted in a decrease of CO, oxidative stress, arterial stiffness and restored endothelial glycocalyx. These effects were more evident after varenicline treatment, likely because of a greater CO reduction, and were maintained after 1 year only in subjects who abstained from smoking. (C) 2017 Elsevier B. V. All rights reserved.